The global pharmaceutical plastic bottle industry is nearing a valuation of USD 30 billion in 2024 and is forecast to reach a value of USD 49 billion by 2034. Sales are projected to rise at a CAGR of 5% through 2034. The revenue generated by pharmaceutical plastic bottles in 2023 was USD 28.8 billion. The industry is anticipated to exhibit a Y-o-Y growth of 4.1% in 2024.
Plastic bottles for solid formulations are anticipated to gain a 45% value share by 2034 because they are versatile, low-cost, and convenient for end users. Plastic bottles are lightweight and durable, which makes them ideal for solid formulations. Most medicines available in the market are in solid dosage, which results in high demand for pharmaceutical bottles for solid formulations. is resulting in high demand for pharmaceutical bottles for solid formulations.
Polyethylene terephthalate (PET) bottles are the most used packaging format which is anticipated to gain USD 15.8 billion revenue by 2034. Exceptional barrier properties of PET bottles, which protect the medicines from light, moisture, and oxygen are boosting its application in the pharmaceutical industry.
PET bottles have enhanced transparency, which allows healthcare professionals and patients to visually inspect the contents, detect tampering, and verify accurate labels. PET bottles have enhanced transparency which allows healthcare professional and patients to visually inspect the contents, detect tampering, and verify accurate labels.
Plastic bottles with a capacity below 100 ml are mostly utilized in the pharmaceutical industry. It is anticipated to be more than half of the value share by 2034, driven by its compactness and portability, especially for on-the-go purposes.
Small-size bottles also facilitate patients' medication consumption in smaller quantities. 2034 end driven by it compactness and portability especially for on the go porpose. Small size bottles also facilitates patients to medication consumption in smaller qualities.
The pharmaceutical plastic bottle industry is set to experience profitable growth during the forecast period. It is projected to create an incremental opportunity of USD 20.1 billion and is predicted to rise 1.7 times the current value through 2034.
Pharmaceutical packaging is expected to drive the market due to the growing demand for the storage and delivery of medicines and the rising need for healthcare services.
Increasing sustainability concerns are generating the demand for 100% recycled pharmaceutical plastic bottles and, consequently, manufacturers using recycled plastic for the production of pharmaceutical plastic bottles. Advancements in technology and the use of plastic bottles for solid and liquid oral medicines have contributed to the growth of the pharmaceutical plastic bottle industry.
Other features that have led to increased adoption in the pharmaceutical industry include a barrier against moisture, high dimensional stability, high impact strength, resistance to strain, low water absorption, transparency, heat and flame resistance, and extension of expiration dates.
pharmaceutical plastic bottles and consequently manufacturer using recycled plastic for the production of pharmaceutical plastic bottles. Advancements in technology and the use of plastic bottles for solid and liquid oral medicines have contributed to the growth of the pharmaceutical plastic bottle industry.
Other features that have led to increased adoption in the pharmaceutical industry include a barrier against moisture, high dimensional stability, high impact strength, resistance to strain, low water absorption, transparency, heat, and flame resistance, and extension of expiration dates.
Global Pharmaceutical Plastic Bottle Industry Assessment
| Attributes | Key Insights |
|---|---|
| Historical Pharmaceutical Plastic Bottle Industry Size (2023) | USD 28,854.6 million |
| Estimated Pharmaceutical Plastic Bottle Market Size (2024E) | USD 30,051.9 million |
| Projected Global Pharmaceutical Plastic Bottle Market Value (2034F) | USD 49,032 million |
| Value-based CAGR (2024 to 2034) | 5% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Growing Demand for Anti-counterfeit and Child Resistant Pharmaceutical Plastic Bottle
The pharmaceutical packaging industry has seen an enhancement in the demand for counterfeit protection solutions and child-resistant packaging solutions in the past couple of years. In the pharmaceutical industry, counterfeiting has been a major cause of concern for manufacturers as well as consumers. The introduction of anti-counterfeit technologies like barcodes, labels, tags, etc., to minimize this problem is gaining traction among the manufacturers of the pharmaceutical plastic bottles market.
The increase in the number of poisoning cases in underage children caused by accidental ingestion of medicines boosted the introduction of child-resistant packaging solutions in the industry. Many key players in the industry started offering these bottles with child-resistant closures to prevent accidental ingestion of medicines. For Instance, Berry Global Healthcare, in February 2023, launched a comprehensive bundle solution to help customers capitalize on the increasing demand for child-resistant (CRC) and tamper-evident (TE) packaging for the pharmaceutical and herbal market for syrup and liquid medicines.
Biopharmaceuticals Industry Strongly Contributes to Market Growth
Biopharmaceutical industry plays a crucial role in the well-functioning of healthcare systems and the development of new medicines and vaccines for the prevention of diseases and treatments. Biopharmaceutical product sales are growing and continue to stay driven by highly intensive research and development in the sector. Medicines are effectively contributing to the healthcare system's sustainability by reducing the cost of medical treatments and cost of long-term care.
The healthcare sector has remarkably grown, driven by the rising necessity of health and wellness. The increasing occurrence of diseases and viruses has increased the development and consumption of medications in the forecast period. Increasing health problems among people driven by unhealthy lifestyles are generating the demand for new and improved treatment. These developments in the healthcare sector are significantly increasing the demand for pharmaceutical plastic bottles.
Spurring Demand for Blister Packaging May Hamper the Market Growth
The availability of alternatives, such as blister packaging, may impede the growth of pharmaceutical plastic bottle market growth. Alternative packaging solutions are being introduced that are more cost-efficient than plastic bottles in the market. Blister packaging is one such alternative that is widely used as a convenient and economical alternative to pharmaceutical plastic bottles.
The blister packs require less storage space, offer visibility of inside contents, and restrict the movement of its contents during transportation, adding additional safety to the product. Further, the blister packs also reduce the chances of missing prescribed dosages and consumption of additional dosages, making them popular among consumers. Additionally, rising concerns over plastic pollution and the imposition of stricter regulations on plastic usage on the environment are some of the key factors resisting the market expansion.
The global market recorded a CAGR of 3.7% during the historical period between 2019 and 2023. The growth of the pharmaceutical plastic bottle industry was positive as it reached a value of USD 28.8 billion in 2023 from USD 24.9 million in 2019.
Pharmaceutical plastic bottles are driven by the need to meet stringent packaging standards to ensure the safety of patients. Manufacturers are combating ways to provide solutions that preserve the medicines while maintaining the sustainability factor.
Consumers are also inclined towards eco-friendly packaging solutions. This has generated the need for producing plastic bottles using recycled plastic for the pharmaceutical industry ensuring the safety of the medicines.
Companies are moving towards using biodegradable and compostable materials in manufacturing plastic bottles. Companies also incorporate QR codes that enable providing necessary information and easy tracking in the suppler chain.
It also enables to identification of the originality of the products, combating counterfeiting. Rising health concerns and disease due to growing urbanization have been pushing the demand for prominent and improvised healthcare services across regions.
Plastic bottles are increasingly used in pharmaceuticals because they are easily available, lightweight, safe, and inexpensive. Increasing demand for oral drugs and over-the-counter sales are pushing the market forward. Continuous innovation and development in healthcare for improved medication and treat new emerging diseases is boosting the demand for pharmaceutical plastic bottles.
Plastic bottles are reliable packaging solutions for a range of medicines and healthcare products. They keep the products fresh and safe for consumption. Ongoing research and developments on combining the need for security with usability are leading beyond the mechanical characteristics. For instance, an ID-cap is a biometric recognition integrated capsule that helps to easily open the product by fingertips and twist caps are being offered by Bormioli Pharma.
Increasing demand for personalized and specialized medical treatments is translating into growing investment in the research and development of modern medicines. The growth in medical innovation is supplementing the demand for reliable and effective packaging ensuring optimal protection with sustainability.
Principal Consultant
The section below covers the industry analysis for the pharmaceutical plastic bottles market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, South Asia, Europe, East Asia, and others, is provided.
Russia is anticipated to remain leading in Europe, with a value share of more than 18.3% through 2034. In North America, Canada is projected to witness a remarkable CAGR of 5.3% by 2034.
| Countries | Value CAGR (2024 to 2034) |
|---|---|
| Canada | 5.3% |
| Argentina | 6.6% |
| Germany | 2.9% |
| China | 5.4% |
| Malaysia | 7.6% |
| Turkey | 7.3% |
| Australia | 5.3% |
The United States is projected to generate USD 6.8 billion in revenue and capture a 78.3% value share by 2034. The rising demand for excellent healthcare faculties in the USA driven by favorable healthcare policies and services has supplemented the healthcare sector of the USA.
PETERSON-KFF Health System Tracker reported that the USA recorded the highest per capita healthcare spending of USD 12,555 million in 2022. This value is over USD 4,000 million more than the other nations with high income. Increasing healthcare spending will supplement the demand for plastic bottles in the region, particularly for in-house and outpatient healthcare services.
The USA has experienced a rise in several chronic diseases and healthcare issues, which will boost the demand for medications. The rising prevalence of pandemics and contagious viruses has necessitated innovation for plastic bottles for better prevention and medication administration.
India is anticipated to generate incremental opportunity worth USD 2 billion and capture a 48.7% value share during the forecast period. India Brand Equity Foundation (IBEF) estimated that the Indian pharmaceutical industry is witnessing remarkable growth, with revenue of USD 65 billion in 2024, and it is anticipated to reach 450 billion by 2030.
India’s pharmaceutical industry is expanding due to rising consensus to provide innovative treatments and therapies to patients. Indian pharmaceutical industry is known for its low-cost generic medicines contributing to sales of pharmaceutical plastic bottles.
The country covers the demand for 40% of generic pharmaceutical plastic bottles needed in the U.S. and 25% of all medication within the U.K. India has 3,000 drug companies and 10,500 manufacturing facilities that are supplementing the demand for plastic bottles. India is continually innovating and developing drugs to treat numerous diseases at the lowest cost and highest quality, resulting in its preference worldwide.
India has a major share in generic drugs, bulk drugs, and OTC medications, which will create a future growth opportunity for the plastic bottles industry.
The aged population generally consumes more medications regularly because of the high prevalence of chronic diseases and other health issues due to age. This is likely to generate the demand for pharmaceuticals pushing the sales of plastic bottles in Japan since they are easy and trouble-free to use.
The lightweight and sturdy nature of plastic bottles facilitates elder people in handling medicines. There is also more focus on preventive medications such as vitamins and supplements to manage wellbeing over the years. Japan is anticipated to be at 7% CAGR holding 33.5% of the market share by 2034
The section contains information about the leading segments in the industry. Plastic bottles for solid formulations are leading in the global industry, with an estimated market share of 44.3% in 2024.
PET bottles are taking prominence over the pharmaceutical industry which is anticipated to grow further at 6% CAGR by 2034. Pharmaceutical plastic bottles within below 100 ml capacity range projected to have revenue of USD 14.8 billion by 2024.
| Bottle Type | Plastic Bottles for Solid Formulations |
|---|---|
| Value Share (2034) | 40.6% |
Plastic bottles for solid formulations are a leading contributor to pharmaceutical plastic bottle industry's growth. The target segment is anticipated to generate revenue of USD 13.3 billion by 2024 end and lead to a gain of 2/5th of revenue share by the the assessment period.
Solid formulations such as tablets and capsules are highly consumed by patients because they are easy to administer and have dosage accuracy. Solid medicines are less susceptible to damage by contamination, providing longer shelf life and retaining the effectiveness of medications. Plastic bottles provide cost-effective, durable, lightweight, and barrier properties, which make them ideal for solid formulation packaging.
Plastic bottles are leading among the bottle types as they can be easily customized for different needs, shapes and sizes. Manufacturers prefer these bottle types as they can be incorporated with tamper evident and child-resistance closures, ensuring safe medication storage.
Consumers prefer plastic bottles because they are easy to handle and provide clear labeling for patients, ensuring easy medication administration.
| Material | Polyethylene terephthalate (PET) |
|---|---|
| Value Share (2034) | 32.3% |
The polyethylene terephthalate bottle is expected to surpass a valuation of USD 15.8 billion in 2034. The use of PET bottles in pharmaceutical sector is growing at a comparatively higher rate, recording a 6% CAGR during the upcoming decade.
The increasing restrictions and regulations globally on the usage of plastics have compelled manufacturers to increase the utilization of recycled polyethylene terephthalate for the production of pharmaceutical plastic bottles. Polyethylene terephthalate offers comparatively higher barrier strength and recyclability, making it a favorable choice.
Polyethylene bottle are also anticipated to contribute a significant revenue of USD 8.6 billion in 2024, expanding 1.6 times its current market value over assessment years. PE bottle provides excellent chemical resistance, durability, and flexibility which ensures the stability and integrity of medications. PE bottles provide high barrier against moisture and they are shatterproof which is essential for medicines in storage and transportation.
| Capacity | Below 100 ml |
|---|---|
| Value Share (2034) | 52.9% |
Pharmaceutical bottles with a capacity below 100 ml are anticipated to hold a major market share by 2034 accounting for more than half of the market. The demand for below 100 capacity bottles is experiencing an upward trend with an increasing preference towards smaller packaging.
Smaller bottles provide accuracy and precise doing of medications suitable for patients. The trend of single-dose packaging offers medication adherence and reduces wastage. They are also easy to carry which makes them a convenient option for patients.
Below 100 ml capacity bottles are widely used in the packaging of ophthalmic and nasal formulations which is projected to witness prominent growth in the upcoming period. The segment will expand 1.8 times its current market value during the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key players in pharmaceutical plastic bottles increasingly investing in automation and advanced technologies to improve efficiency and quality. Companies are adopting the new trends and developing products using recycled, and lightweight materials. Companies are adopting strategies for acquisitions, collaborations, and expansions. Companies are exploring emerging markets to boost sales and market share.
Recent Developments in Pharmaceutical Plastic Bottle Market:
The industry is segregated into plastic bottles for solid formulations, plastic bottles for liquid formulations, and plastic bottles for ophthalmic or nasal formulations.
In terms of material, the industry is divided into polyethylene terephthalate (PET), polypropylene (PP), polyethylene (PE), and polyvinyl chloride (PVC). Polyethylene is further segmented as low density polyethylene (LDPE) and high density polyethylene (HDPE).
Few of the important capacities include below 100 ml, 100 to 250 ml and above 250 ml.
Key countries of North America, Latin America, South Asia, East Asia, Europe, Oceania, and the Middle East and Africa are covered.
The global pharmaceutical plastic bottle industry is projected to witness a CAGR of 5% through 2034.
The global pharmaceutical plastic bottle industry stood at USD 28.8 billion in 2023.
Global pharmaceutical plastic bottle industry is anticipated to reach USD 40 billion by 2034
Middle East and Africa is set to record a CAGR of 6.6% in assessment period.
Berry Global Inc, Amcor Plc, and AptarGroup, Inc.
1. Executive Summary 2. Industry Introduction 2.1. Market Taxonomy 2.2. Market Definition 3. Market Trends and Success Factors 4. Market Background 4.1. Macro-economic and Industry Outlook 4.2. Market Dynamics 4.3. Value Chain Analysis 4.4. List of Key Market Participants (Manufacturers/Channel Partners) 4.5. Analysis of Key Industry Matrices 4.6. Industry Development Roadmap 5. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034 5.1. Historical Market Volume Analysis 5.2. Future Market Volume Projections 6. Pricing Analysis 7. Global Market Value (US$) Analysis 2019 to 2023 and Forecast 2024 to 2034 7.1. Historical Sales Analysis 7.2. Future Market Size and Growth Projections 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, Bottle Type 8.1. Plastic Bottles For Solid Formulation 8.2. Plastic Bottles For Liquid 8.3. Plastic Bottles For Ophthalmic/Nasal Formulation 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Material 9.1. Polyethylene (PE) 9.1.1. High-density polyethylene (HDPE) 9.1.2. Low-density polyethylene (LDPE) 9.2. Polyethylene terephthalate (PET) 9.3. Polypropylene (PP) 9.4. Polyvinyl chloride (PVC) 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Capacity 10.1. Below 100 ml 10.2. 100 ml – 250 ml 10.3. Above 250 ml 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region 11.1. North America 11.2. Latin America 11.3. Europe 11.4. East Asia 11.5. South Asia 11.6. Oceania 11.7. Middle East and Africa (MEA) 12. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Market Segments and Country 13. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Market Segments and Country 14. Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Market Segments and Country 15. South Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Market Segments and Country 16. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Market Segments and Country 17. Oceania Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Market Segments and Country 18. Middle East and Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Market Segments and Country 19. Sales Analysis 2024 & 2034 by Key Market Segments for 30 Key Countries 20. Competition Outlook including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 21. Company Profile 21.1. Berry Global Inc. 21.2. Amcor Plc 21.3. Gerresheimer AG 21.4. AptarGroup, Inc 21.5. Alpha Packaging Company 21.6. Mykron Plus India Pvt. Ltd. 21.7. Comar LLC 21.8. Alpack Inc. 21.9. Drug Plastics Group 21.10. ALPLA Werke Alwin Lehner GmbH & Co KG 21.11. Bormioli Pharma S.p.a. 21.12. C.L.Smith Company 21.13. United States Plastic Corporation 21.14. Weener Plastics Group BV 21.15. Origin Pharma Packaging 21.16. Pretium Packaging 21.17. Pro-Pac Packaging Group 21.18. Silgan Holdings Inc 21.19. Frapak Packaging b.v. 21.20. Altium Packaging
Explore Packaging Insights
View Reports
Pharmaceutical Plastic Bottle Market
